Orthofix Medical Inc. (OFIX)
NASDAQ: OFIX · Real-Time Price · USD
14.96
-0.05 (-0.33%)
At close: Nov 14, 2025, 4:00 PM EST
14.95
-0.01 (-0.07%)
After-hours: Nov 14, 2025, 4:20 PM EST
Orthofix Medical Stock Forecast
Stock Price Forecast
The 5 analysts that cover Orthofix Medical stock have a consensus rating of "Strong Buy" and an average price target of $22, which forecasts a 47.06% increase in the stock price over the next year. The lowest target is $18 and the highest is $24.
Price Target: $22 (+47.06%)
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Orthofix Medical stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jun '25 | Jul '25 | Aug '25 | Sep '25 | Oct '25 | Nov '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 3 | 3 | 3 | 4 | 4 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 1 | 1 | 1 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 5 | 5 | 5 | 5 | 6 | 6 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Barrington Research | Barrington Research | Buy Maintains $17 → $18 | Buy | Maintains | $17 → $18 | +20.32% | Nov 5, 2025 |
| Stifel | Stifel | Strong Buy Initiates $22 | Strong Buy | Initiates | $22 | +47.06% | Oct 28, 2025 |
| Barrington Research | Barrington Research | Buy Maintains $17 | Buy | Maintains | $17 | +13.64% | Oct 23, 2025 |
| Barrington Research | Barrington Research | Buy Maintains $17 | Buy | Maintains | $17 | +13.64% | Sep 23, 2025 |
| Barrington Research | Barrington Research | Buy Initiates $16 | Buy | Initiates | $16 | +6.95% | Jun 23, 2025 |
Financial Forecast
Revenue This Year
829.83M
from 799.49M
Increased by 3.79%
Revenue Next Year
876.79M
from 829.83M
Increased by 5.66%
EPS This Year
-2.26
from -3.30
EPS Next Year
-1.61
from -2.26
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|
| High | 856.3M | 911.7M | ||
| Avg | 829.8M | 876.8M | ||
| Low | 794.8M | 829.8M |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|
| High | 7.1% | 9.9% | ||
| Avg | 3.8% | 5.7% | ||
| Low | -0.6% | -0.0% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | -1.58 | -0.70 | |
| Avg | -2.26 | -1.61 | |
| Low | -2.66 | -2.20 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | - | - | |
| Avg | - | - | |
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.